285 related articles for article (PubMed ID: 36381603)
1. Penile cancer: Updates in systemic therapy.
Joshi VB; Chadha J; Chahoud J
Asian J Urol; 2022 Oct; 9(4):374-388. PubMed ID: 36381603
[TBL] [Abstract][Full Text] [Related]
2. An update on treatment of penile cancer.
Chadha J; Chahoud J; Spiess PE
Ther Adv Med Oncol; 2022; 14():17588359221127254. PubMed ID: 36172172
[TBL] [Abstract][Full Text] [Related]
3. Immune-based therapies in penile cancer.
Joshi VB; Spiess PE; Necchi A; Pettaway CA; Chahoud J
Nat Rev Urol; 2022 Aug; 19(8):457-474. PubMed ID: 35851333
[TBL] [Abstract][Full Text] [Related]
4. Second line salvage systemic therapy for advanced penile cancer.
Chahoud J; Tamil M; Necchi A
Urol Oncol; 2022 Jun; 40(6):229-234. PubMed ID: 32950396
[TBL] [Abstract][Full Text] [Related]
5. Management of Advanced Penile Cancer.
Chahoud J; Kohli M; Spiess PE
Mayo Clin Proc; 2021 Mar; 96(3):720-732. PubMed ID: 33308870
[TBL] [Abstract][Full Text] [Related]
6. Management guidelines of penile cancer- a contemporary review of sub-Saharan Africa.
Cassell A; Yunusa B; Manobah B; Wambo D
Infect Agent Cancer; 2020; 15():26. PubMed ID: 32377231
[TBL] [Abstract][Full Text] [Related]
7. [Systemic treatment of locally advanced or metastatic penile cancer].
Gassian N; Frontczak A; El Kaddissi A; Calcagno F; Almotlak H; Barkatz J; Mouillet G; Maurina T; Stein U; Nguyen Tan Hon T; Murez T; Thiery-Vuillemin A
Bull Cancer; 2020 Jun; 107(5S):S17-S23. PubMed ID: 32620202
[TBL] [Abstract][Full Text] [Related]
8. Emerging Therapies in Penile Cancer.
Alencar AM; Sonpavde G
Front Oncol; 2022; 12():910335. PubMed ID: 35800050
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and Predictive Factors in Patients with Advanced Penile Cancer Receiving Salvage (2nd or Later Line) Systemic Treatment: A Retrospective, Multi-Center Study.
Buonerba C; Di Lorenzo G; Pond G; Cartenì G; Scagliarini S; Rozzi A; Quevedo FJ; Dorff T; Nappi L; Lanzetta G; Pagliaro L; Eigl BJ; Naik G; Ferro M; Galdiero M; De Placido S; Sonpavde G
Front Pharmacol; 2016; 7():487. PubMed ID: 28066240
[No Abstract] [Full Text] [Related]
10. An update on systemic therapy for penile cancer.
Resch I; Abufaraj M; Hübner NA; Shariat SF
Curr Opin Urol; 2020 Mar; 30(2):229-233. PubMed ID: 31972637
[TBL] [Abstract][Full Text] [Related]
11. Systematic Review and Meta-Analysis-Is there a Benefit in Using Neoadjuvant Systemic Chemotherapy for Locally Advanced Penile Squamous Cell Carcinoma?
Azizi M; Aydin AM; Hajiran A; Lai A; Kumar A; Peyton CC; Minhas S; Sonpavde GP; Chahoud J; Pagliaro LC; Necchi A; Spiess PE
J Urol; 2020 Jun; 203(6):1147-1155. PubMed ID: 31928407
[TBL] [Abstract][Full Text] [Related]
12. Current concepts in penile cancer.
Spiess PE; Horenblas S; Pagliaro LC; Biagioli MC; Crook J; Clark PE; Greenberg RE; Ercole CE
J Natl Compr Canc Netw; 2013 May; 11(5):617-24. PubMed ID: 23667210
[TBL] [Abstract][Full Text] [Related]
13. What's new in the management of penile cancer?
Busby JE; Pettaway CA
Curr Opin Urol; 2005 Sep; 15(5):350-7. PubMed ID: 16093861
[TBL] [Abstract][Full Text] [Related]
14. Advanced penile carcinoma.
Culkin DJ; Beer TM
J Urol; 2003 Aug; 170(2 Pt 1):359-65. PubMed ID: 12853775
[TBL] [Abstract][Full Text] [Related]
15. Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy.
Pond GR; Di Lorenzo G; Necchi A; Eigl BJ; Kolinsky MP; Chacko RT; Dorff TB; Harshman LC; Milowsky MI; Lee RJ; Galsky MD; Federico P; Bolger G; DeShazo M; Mehta A; Goyal J; Sonpavde G
Urol Oncol; 2014 May; 32(4):501-8. PubMed ID: 24332646
[TBL] [Abstract][Full Text] [Related]
16. Metastatic penile squamous cell carcinoma with dramatic response to combined checkpoint blockade with ipilimumab and nivolumab.
Baweja A; Mar N
J Oncol Pharm Pract; 2021 Jan; 27(1):212-215. PubMed ID: 32380900
[TBL] [Abstract][Full Text] [Related]
17. Updates in the molecular epidemiology and systemic approaches to penile cancer.
Adashek JJ; Necchi A; Spiess PE
Urol Oncol; 2019 Jul; 37(7):403-408. PubMed ID: 31053523
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations.
Ali SM; Pal SK; Wang K; Palma NA; Sanford E; Bailey M; He J; Elvin JA; Chmielecki J; Squillace R; Dow E; Morosini D; Buell J; Yelensky R; Lipson D; Frampton GM; Howley P; Ross JS; Stephens PJ; Miller VA
Oncologist; 2016 Jan; 21(1):33-9. PubMed ID: 26670666
[TBL] [Abstract][Full Text] [Related]
19. Activity and tolerability of maintenance avelumab immunotherapy after first line polychemotherapy including platinum in patients with locally advanced or metastatic squamous cell penile carcinoma: PULSE.
Gassian N; Frontczak A; Mouillet G; Vernerey D; Manseur O; Goujon M; Meurisse A; Berthod D; Robert E; Calcagno F; Thiery-Vuillemin A
Bull Cancer; 2020 Jun; 107(5S):eS16-eS21. PubMed ID: 32620211
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
